34.77
price up icon1.40%   0.48
after-market 시간 외 거래: 34.77
loading

Exelixis Inc 주식(EXEL)의 최신 뉴스

pulisher
07:26 AM

Exelixis EVP sells $1.7 million in stock - Investing.com

07:26 AM
pulisher
07:21 AM

Exelixis director George Poste sells $1.02 million in shares By Investing.com - Investing.com Australia

07:21 AM
pulisher
04:33 AM

Earnings Estimates Rising for Exelixis (EXEL): Will It Gain? - MSN

04:33 AM
pulisher
04:27 AM

Exelixis (NASDAQ:EXEL) Sets New 52-Week HighTime to Buy? - MarketBeat

04:27 AM
pulisher
12:45 PM

Here is Why Growth Investors Should Buy Exelixis (EXEL) Now - Yahoo Finance

12:45 PM
pulisher
09:23 AM

Capital Management Corp VA Increases Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

09:23 AM
pulisher
08:44 AM

Exelixis's SWOT analysis: oncology leader's stock poised for growth - Investing.com

08:44 AM
pulisher
Nov 04, 2024

Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook - MSN

Nov 04, 2024
pulisher
Nov 03, 2024

3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool

Nov 03, 2024
pulisher
Nov 03, 2024

New York State Teachers Retirement System Raises Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Dana Aftab Sells 1,162 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis (NASDAQ:EXEL) Issues Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Trend Tracker for (EXEL) - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis price target raised to $38 from $33 at Truist - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Stephens Investment Management Group LLC Has $98.78 Million Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis stock hits 52-week high at $31.3 amid robust growth - Investing.com Australia

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis, Inc.'s (NASDAQ:EXEL) Shares Leap 25% Yet They're Still Not Telling The Full Story - Simply Wall St

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Exelixis reports solid growth, raises 2024 revenue guidance - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Exelixis reports solid growth, raises 2024 revenue guidance By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis price target raised to $36 from $33 at Piper Sandler - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

DekaBank Deutsche Girozentrale Acquires 30,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Exelixis Inc (EXEL) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis EVP Jeffrey Hessekiel sells $709,750 in stock - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis stock hits 52-week high at $31.3 amid robust growth By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Royal Bank of Canada Reiterates Outperform Rating for Exelixis (NASDAQ:EXEL) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis shares target lifted, retains equal weight on strong Q3 results - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis (NASDAQ:EXEL) Hits New 1-Year High Following Analyst Upgrade - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Stephens Boosts Exelixis (NASDAQ:EXEL) Price Target to $29.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Piper Sandler boosts Exelixis stock target on earnings beat and optimistic revenue outlook - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

FY2024 EPS Estimates for Exelixis Reduced by Leerink Partnrs - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis stock sees upside with cabozantinib’s patent extension and label expansion - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis Reports Strong Q3 2024 Earnings and Pipeline Expansion - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis Inc (EXEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis Earnings: Raising Valuation on Improved Outlook Thanks to Pipeline Candidate Zanzalintinib - Morningstar

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis Inc (EXEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

No-Moat Exelixis Focuses on Developing Pipeline to Offset Future Generic Entry for Cabozantinib - Morningstar

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis: Q3 Earnings Snapshot - The Advocate

Oct 30, 2024
pulisher
Oct 30, 2024

Exelixis (EXEL) Q3 2024 Earnings Call Transcript - Yahoo! Voices

Oct 30, 2024
pulisher
Oct 29, 2024

Exelixis Inc (EXEL) Q3 2024 Earnings: EPS of $0.40 Beats Estimat - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Exelixis (EXEL) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Exelixis (EXEL) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Exelixis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Buys 20,641 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Q4 Earnings Estimate for Exelixis Issued By Leerink Partnrs - MarketBeat

Oct 29, 2024
pulisher
Oct 26, 2024

Assenagon Asset Management S.A. Sells 588,870 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Oct 24, 2024
pulisher
Oct 24, 2024

Exelixis's SWOT analysis: cabozantinib drives growth amid patent challenges By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Exelixis's SWOT analysis: cabozantinib drives growth amid patent challenges - Investing.com India

Oct 24, 2024
pulisher
Oct 23, 2024

Here's Why Exelixis (EXEL) is a Great Momentum Stock to Buy - Yahoo Finance

Oct 23, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):